Evidence map›Paper›PMID 30923040›Full record

ArticleBlood2019

Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia.

Emanuela M Ghia, Laura Z Rassenti, Donna S Neuberg, Alejandro Blanco, Fouad Yousif, Erin N Smith, John D McPherson, Thomas J Hudson, HALT Pan-Leukemia Gene Panel Consortium, Olivier Harismendy and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Emanuela M GhiaMoores Cancer Center, University of California San Diego, La Jolla, CA.ORCID 0000-0002-6060-6106
Laura Z RassentiMoores Cancer Center, University of California San Diego, La Jolla, CA.
Donna S NeubergBiostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-2566-3145
Alejandro BlancoPrograma de Genetica Humana, Universidad de Chile, Santiago, Chile.
Fouad YousifOntario Institute for Cancer Research, Toronto, ON, Canada.
Erin N SmithDepartment of Pediatrics and Rady Children's Hospital, University of California San Diego, La Jolla, CA.ORCID 0000-0001-9632-4760
John D McPhersonDepartment of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA; and.ORCID 0000-0001-8049-9347
Thomas J HudsonOntario Institute for Cancer Research, Toronto, ON, Canada.ORCID 0000-0002-1376-4849
HALT Pan-Leukemia Gene Panel Consortium
Olivier HarismendyMoores Cancer Center, University of California San Diego, La Jolla, CA.ORCID 0000-0002-8098-9888
Kelly A FrazerMoores Cancer Center, University of California San Diego, La Jolla, CA.ORCID 0000-0002-6060-8902
Thomas J KippsMoores Cancer Center, University of California San Diego, La Jolla, CA.ORCID 0000-0002-0064-4549
University of California San Diego · USOntario Institute for Cancer Research · CADana-Farber Cancer Institute · USUniversity of California, Davis · USUniversity of Chile · CL

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
iDASH: Integrating Data for Analysis, Anonymization, and SharingU54HL108460 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OHNO-MACHADO, LUCILA · 2010 to 2015
$19.1M
ANTIBODY V GENE EXPRESSION IN B CELL CLLR37CA049870 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 1994 to 2013
$4.5M
Non-canonical Wnt-Receptor Signaling and Targeted TherapiesR01CA236361 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2019 to 2023
$3.2M
In vivo detection and genome-wide location analysis of DNA-adductsR21CA177519 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HARISMENDY, OLIVIER, HOWELL, STEPHEN B · 2013 to 2015
$667k
Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor SyndromeR21CA192072 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SICKLICK, JASON KEITH · 2016 to 2017
$399k
Biomarkers of Disease Progression in CLLR21CA152613 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRAZER, KELLY A · 2010 to 2011
$367k
NCI NIH HHS P01 CA081534NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA236361NCI NIH HHS R21 CA152613NCI NIH HHS R21 CA177519NCI NIH HHS R21 CA192072NCI NIH HHS R37 CA049870NHLBI NIH HHS U54 HL108460
6 · The paper itself

Abstract

Targeted sequencing of 103 leukemia-associated genes in leukemia cells from 841 treatment-naive patients with chronic lymphocytic leukemia (CLL) identified 89 (11%) patients as having CLL cells with mutations in genes encoding proteins that putatively are involved in hedgehog (Hh) signaling. Consistent with this finding, there was a significant association between the presence of these mutations and the expression of GLI1 (χ

Indexed as

AdultAgedAged, 80 and overDisease ProgressionFemaleGene Expression Regulation, LeukemicHedgehog ProteinsHumansLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedPyridinesPyrimidinesSignal TransductionZinc Finger Protein GLI1GANT 61GLI1 protein, humanHedgehog ProteinsPyridinesPyrimidinesZinc Finger Protein GLI1

Identifiers

PMID30923040
PMCPMC6587306
OpenAlexW2928495578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.